Skip to main content

Table 5 Mutational frequencies of levofloxacin, vancomycin, teicoplanin, amikacin, ceftazidime, cefepime, imipenem and piperacillin/tazobactam alone and in triple combinations

From: In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureussevere respiratory infections

Strain

LVX

VA

TEC

AMK

CAZ

FEP

IPM

TZP

Triple combinations*

7095

<10-9

<10-9

<10-9

4.52 × 10-7

n.d.

n.d.

n.d.

<10-9

<10-9

7096

<10-9

<10-9

<10-9

1.6 × 10-7

n.d.

n.d.

1.03 × 10-6

n.d.

<10-9

8957

4.9 × 10-5

<10-9

<10-9

<10-9

n.d.

n.d.

n.d.

n.d.

<10-9

7176

2.4 × 10-6

<10-9

<10-9

3.65 × 10-8

n.d.

n.d.

8.52 × 10-5

n.d.

<10-9

7171

<10-9

<10-9

<10-9

7.57 × 10-7

n.d.

n.d.

n.d.

n.d.

<10-9

2106

n.d.

<10-9

<10-9

<10-9

n.d.

n.d.

2.3 × 10-5

n.d.

<10-9

7117

n.d.

<10-9

<10-9

7.24 × 10-7

n.d.

n.d.

n.d.

n.d.

<10-9

7169

n.d.

<10-9

<10-9

<10-9

n.d.

n.d.

n.d.

n.d.

<10-9

6491

n.d.

<10-9

<10-9

6 × 10-8

n.d.

n.d.

n.d.

n.d.

<10-9

  1. LVX: levofloxacin; VA: vancomycin; TEC: teicoplanin; AMK: amikacin; CAZ: ceftazidime; FEP: cefepime; IPM: imipenem; TZP: piperacillin/tazobactam.
  2. n.d.: not determined (strain resistant to the antibiotic)
  3. *Triple combinations: LVX+VA+AMK; LVX+VA+CAZ; LVX+VA+FEP; LVX+VA+IPM; LVX+VA+TZP; LVX+VA+AMK; LVX+TEC+CAZ; LVX+TEC+FEP; LVX+TEC+IPM; LVX+TEC+TZP.